Analysts Set HealthEquity, Inc. (NASDAQ:HQY) PT at $110.71

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the fourteen brokerages that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $110.71.

HQY has been the topic of a number of analyst reports. JMP Securities lifted their target price on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Tuesday, December 10th. BTIG Research lifted their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a report on Thursday, November 14th. The Goldman Sachs Group started coverage on HealthEquity in a report on Friday, November 15th. They set a "neutral" rating and a $108.00 target price for the company. Barrington Research raised their price target on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a research report on Monday, December 2nd. Finally, Bank of America increased their price objective on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a research note on Wednesday, November 13th.

HealthEquity Price Performance

NASDAQ HQY traded up $1.27 during trading hours on Thursday, hitting $110.07. The company had a trading volume of 201,861 shares, compared to its average volume of 714,966. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm has a market capitalization of $9.54 billion, a price-to-earnings ratio of 100.97, a PEG ratio of 1.86 and a beta of 0.54. HealthEquity has a 52 week low of $65.01 and a 52 week high of $111.36. The firm has a 50 day simple moving average of $99.85 and a 200 day simple moving average of $88.02.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the prior year, the business earned $0.40 earnings per share. Equities research analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Frank Corvino sold 1,039 shares of the firm's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now owns 3,784 shares of the company's stock, valued at approximately $363,642.40. This trade represents a 21.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Robert W. Selander sold 8,250 shares of the business's stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now directly owns 66,469 shares of the company's stock, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 34,289 shares of company stock worth $3,355,718. 2.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Bank of Montreal Can boosted its stake in HealthEquity by 10.5% in the 2nd quarter. Bank of Montreal Can now owns 11,308 shares of the company's stock worth $976,000 after purchasing an additional 1,077 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in shares of HealthEquity by 0.8% in the second quarter. The Manufacturers Life Insurance Company now owns 104,494 shares of the company's stock worth $9,007,000 after buying an additional 879 shares in the last quarter. Algert Global LLC bought a new position in shares of HealthEquity during the second quarter worth $748,000. Creative Planning grew its stake in HealthEquity by 25.0% during the second quarter. Creative Planning now owns 19,926 shares of the company's stock valued at $1,718,000 after acquiring an additional 3,983 shares in the last quarter. Finally, Truist Financial Corp increased its holdings in HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company's stock valued at $247,000 after acquiring an additional 188 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.